Stereotaxis, Inc. (STXS)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
After hours:
| Previous close | 2.1000 |
| Open | 2.0700 |
| Bid | 2.0600 x 900 |
| Ask | 2.0700 x 900 |
| Day's range | 2.0500 - 2.1200 |
| 52-week range | 1.3300 - 3.2900 |
| Volume | |
| Avg. volume | 333,096 |
| Market cap | 171.485M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2600 |
| Earnings date | 08 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.60 |
GlobeNewswireStereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024, scheduled to take place during Heart Rhythm Society Scientific Sessions this week in Boston, Massachusetts. Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-qualit
ZacksStereotaxis (STXS) Inks Deal to Buy Access Point Technologies
Stereotaxis' (STXS) deal to acquire electrophysiology catheter developer, Access Point Technologies, is likely to strengthen its position within the catheter market.
- Thomson Reuters StreetEvents
Q1 2024 Stereotaxis Inc Earnings Call
Q1 2024 Stereotaxis Inc Earnings Call
© 2024 Yahoo. All rights reserved.